Aurora Spine
Logotype for Aurora Spine Corp

Aurora Spine (ASG) investor relations material

Aurora Spine Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Aurora Spine Corp
Q4 2025 earnings summary30 Apr, 2026

Executive summary

  • Achieved record annual and Q4 2025 revenue, with Q4 marking the first $5 million revenue quarter in company history and fiscal 2025 revenue reaching $18.4 million, up 4.6% year-over-year.

  • Strong momentum attributed to expanded internal sales force, successful proprietary product launches (ZIP, SiLO, DEXA-L), and the launch of Aurora Biologics.

  • Launched DEXA-L, the first bone density-matched lumbar implant, and prepared for DEXA-C and other product extensions in 2026.

  • Two new product extensions planned for 2026, including a disposable kit for SI joint pain and further DEXA-enabled products.

  • Expanded sales and marketing team, with new hires covering previously uncovered territories and increased advanced training for physicians.

Financial highlights

  • Q4 2025 revenue reached $5.02 million, up 14% sequentially and 7% year-over-year; fiscal 2025 revenue was $18.4 million, up from $17.6 million in 2024.

  • Gross profit margin improved to 62.4% in Q4 2025 from 57.8% in Q4 2024; fiscal 2025 gross margin was 61%.

  • Q4 2025 net loss narrowed to $41,000 from $653,000 in Q4 2024; fiscal 2025 net loss was $731,000, improved from $1 million in 2024.

  • EBITDAC for Q4 2025 was $301,000, up from $165,000 in Q3 and a loss of $320,000 in Q4 2024; fiscal 2025 EBITDAC was $587,000, up 108% from 2024.

  • Ended the year with nearly $99,000 in cash and improved accounts receivable collections, including $202 million collected in December.

Outlook and guidance

  • Anticipates continued sales momentum and growth in 2026, with seasonality expected but a stronger start than the previous year.

  • Expects new product launches and expanded sales force to drive further revenue growth.

  • Focused on achieving cash flow positivity and leveraging new biologic and DEXA product lines.

Internal sales force impact on 2026 margins
DEXA platform differentiation in bone density
Biologics pull-through strategy for 2026
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Aurora Spine earnings date

Logotype for Aurora Spine Corp
Q1 202621 May, 2026
Aurora Spine
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Aurora Spine earnings date

Logotype for Aurora Spine Corp
Q1 202621 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Explore our global coverage